Login / Signup

Initial combination of metformin, sitagliptin, and empagliflozin in drug-naïve patients with type 2 diabetes: Safety and metabolic effects.

Soo LimMinji SohnYujin ShinEleuterio Ferrannini
Published in: Diabetes, obesity & metabolism (2022)
Keyphrases
  • emergency department
  • adverse drug
  • drug induced